Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CUPID: Post-operative antibiotics for penile prosthesis infection
NCT05100654Phase 1Active, not recruiting
- Sponsor
- University of Chicago
- Start
- Apr 2022
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of doxycycline, ciprofloxacin, amoxicillin + clavulanate and trimethoprim + sulfamethoxazole in penile prosthesis infection, sponsored by University of Chicago. Primary endpoint: Device infection leading to surgical intervention at 12 months. Started Apr 2022; status: active, not recruiting.
02
Drugs
doxycyclineciprofloxacinamoxicillin + clavulanatetrimethoprim + sulfamethoxazole
03
Conditions
penile prosthesis infection
Beyond the preview
Go deeper on NCT05100654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05100654.